Evidence map›Paper›PMID 41255764›Full record

ArticleFrontiers in veterinary science2025

Sumin Cha, Chaewon Shin, Changkeun Kang, Dong-In Jung, Kyu-Woan Cho, Hyeona Bae, Dohyeon Yu

Abstract read
In one paragraph

Article in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sumin ChaCollege of Veterinary Medicine, Gyeongsang National University, Jinju, Republic of Korea.
Chaewon ShinCollege of Veterinary Medicine, Gyeongsang National University, Jinju, Republic of Korea.
Changkeun KangCollege of Veterinary Medicine, Gyeongsang National University, Jinju, Republic of Korea.
Dong-In JungCollege of Veterinary Medicine, Gyeongsang National University, Jinju, Republic of Korea.
Kyu-Woan ChoCollege of Veterinary Medicine, Gyeongsang National University, Jinju, Republic of Korea.
Hyeona BaeCollege of Veterinary Medicine, Gyeongsang National University, Jinju, Republic of Korea.
Dohyeon YuCollege of Veterinary Medicine, Gyeongsang National University, Jinju, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Interest in lyophilized plasma products has increased. However, data on their use in dogs are limited. This study aimed to evaluate the Methods: Ten canine plasma units were lyophilized and stored at -80 °C, 4 °C, room temperature, and 38 °C for 45 days. The plasma compositions before and after lyophilization were compared to assess the impact of the lyophilization. The following parameters were assessed to evaluate storage stability: blood gas analysis, biochemical parameters, coagulation profiles [prothrombin time (PT); activated partial thromboplastin time (aPTT); fibrinogen concentration; the activities of coagulation factors II, V, VIII, IX, X, and XII, as well as those of antithrombin (AT); and protein C], and kaolin-activated thromboelastography. Aerobic bacterial cultures were performed using thioglycollate broth to assess sterility. Lyophilized plasma samples were reconstituted to 50, 60, 80, and 100% of the original plasma volume to assess the effects of different reconstitution volumes on plasma components. Total protein, albumin, osmolality, selected coagulation factors (II and V), fibrinogen, and AT were measured and compared across the reconstituted groups. Results: Lyophilization decreased the partial pressure of carbon dioxide and increased the pH. No other significant immediate changes were observed. Plasma stored at -80 °C and 4 °C maintained stable biochemical and coagulation profiles over 45 days of storage, with only a slight but statistically significant decrease in fibrinogen concentrations on Days 30 and 45 for refrigerated conditions when compared with post-lyophilization values. Significant reductions in the activities of coagulation factors II, V, and VIII were observed at room temperature by Day 45, whereas PT, aPTT, and thromboelastography remained within normal reference ranges relative to the post-lyophilization values. Storage at 38 °C led to marked deterioration in coagulation function, as evidenced by the prolonged PT and aPTT, substantial decline in fibrinogen concentrations, and >50% reduction in the activity of all assessed coagulation factors relative to the post-lyophilization values. The AT activity declined for all storage groups, whereas protein C and thromboelastography profiles remained relatively stable, except at 38 °C. No bacterial growth was observed in any reconstituted plasma samples across all storage temperature and time points. Reconstitution at lower volumes (50 and 60%) increased the concentrations of albumin and activities of coagulation factors and osmolality. Conclusion: The lyophilization process did not significantly affect the concentrations or activities of major plasma proteins, including coagulation factors and anticoagulant proteins. Storage at -80 °C and 4 °C for 45 days preserved the stability of biochemical and hemostatic parameters. However, storage at room temperature resulted in minor reductions in select coagulation factors (such as factors II, V, and VIII). PT, aPTT, and thromboelastography parameters remained within the normal reference ranges, confirming the short-term stability of the product. Changes in the reconstitution volume affected plasma concentration and highlighted the potential of lyophilized plasma as a rapid resuscitative product in veterinary medicine.

Indexed as

coagulationdoglyophilized plasmaplasmatransfusion

Identifiers

PMID41255764
PMCPMC12621322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.